<DOC>
	<DOC>NCT02967614</DOC>
	<brief_summary>To assess the pharmacokinetic Interaction between Dorzolamide and Brimonidine in healthy male subjects.</brief_summary>
	<brief_title>KJ-TFC-004 Drug-drug Interaction Study</brief_title>
	<detailed_description>Clinical trial to evaluate the influence of drug and drug-drug interactions of Brimonidine and Dorzolamide co-administration on the pharmacokinetics of Brimonidine and pharmacokinetics of Dorzolamide in healthy volunteers</detailed_description>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<criteria>Healthy male adults aged between 19 and 50 during screening period BMI more than 18kg / m2 and less than 30kg / m2 and weight more than 55kg Signed the informed consent form prior to study participation. Presence of medical history or a concurrent disease that may interfere with treatment and safety assessment or completion of this clinical study, including clinically significant disorders in kidney, liver, cardiovascular system, respiratory system, endocrine system, or neuropsychiatric system.</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>